PURE BIOSCIENCE, INC. Quarterly Liabilities, Current in USD from Q2 2011 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Pure Bioscience, Inc. quarterly Liabilities, Current history and growth rate from Q2 2011 to Q1 2025.
Pure Bioscience, Inc. Liabilities, Current for the quarter ending April 30, 2025 was $972K, a 45.9% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2025	$972K	+$306K	+45.9%	Apr 30, 2025	10-Q	2025-06-16
Q4 2024	$866K	+$321K	+58.9%	Jan 31, 2025	10-Q	2025-03-17
Q3 2024	$911K	+$105K	+13%	Oct 31, 2024	10-Q	2024-12-16
Q2 2024	$733K	+$201K	+37.8%	Jul 31, 2024	10-Q	2025-06-16
Q1 2024	$666K	+$97K	+17%	Apr 30, 2024	10-Q	2024-06-14
Q4 2023	$545K	+$82K	+17.7%	Jan 31, 2024	10-Q	2024-03-18
Q3 2023	$806K	+$107K	+15.3%	Oct 31, 2023	10-Q	2023-12-14
Q2 2023	$532K	-$43K	-7.48%	Jul 31, 2023	10-K	2024-10-29
Q1 2023	$569K	+$19K	+3.46%	Apr 30, 2023	10-Q	2023-06-14
Q4 2022	$463K	-$121K	-20.7%	Jan 31, 2023	10-Q	2023-03-17
Q3 2022	$699K	-$129K	-15.6%	Oct 31, 2022	10-Q	2022-12-14
Q2 2022	$575K	-$395K	-40.7%	Jul 31, 2022	10-K	2023-10-30
Q1 2022	$550K	-$388K	-41.4%	Apr 30, 2022	10-Q	2022-06-14
Q4 2021	$584K	-$196K	-25.1%	Jan 31, 2022	10-Q	2022-03-15
Q3 2021	$828K	-$78K	-8.61%	Oct 31, 2021	10-Q	2021-12-15
Q2 2021	$970K	-$542K	-35.8%	Jul 31, 2021	10-K	2022-10-28
Q1 2021	$938K	-$553K	-37.1%	Apr 30, 2021	10-Q	2021-06-15
Q4 2020	$780K	+$88K	+12.7%	Jan 31, 2021	10-Q	2021-03-15
Q3 2020	$906K	+$29K	+3.31%	Oct 31, 2020	10-Q	2020-12-15
Q2 2020	$1.51M	+$774K	+105%	Jul 31, 2020	10-K	2021-10-28
Q1 2020	$1.49M	+$968K	+185%	Apr 30, 2020	10-Q	2020-06-11
Q4 2019	$692K	+$42K	+6.46%	Jan 31, 2020	10-Q	2020-03-12
Q3 2019	$877K	+$305K	+53.3%	Oct 31, 2019	10-Q	2019-12-13
Q2 2019	$738K	-$543K	-42.4%	Jul 31, 2019	10-K	2020-10-08
Q1 2019	$523K	-$100K	-16.1%	Apr 30, 2019	10-Q	2019-06-13
Q4 2018	$650K	-$32K	-4.69%	Jan 31, 2019	10-Q	2019-03-06
Q3 2018	$572K	-$65K	-10.2%	Oct 31, 2018	10-Q	2018-12-13
Q2 2018	$1.28M	-$1.25M	-49.3%	Jul 31, 2018	10-K	2019-10-30
Q1 2018	$623K	-$1.81M	-74.4%	Apr 30, 2018	10-Q	2018-06-13
Q4 2017	$682K	-$1.51M	-68.9%	Jan 31, 2018	10-Q	2018-03-14
Q3 2017	$637K	-$2.21M	-77.6%	Oct 31, 2017	10-Q	2017-12-14
Q2 2017	$2.53M	-$8K	-0.32%	Jul 31, 2017	10-K	2018-10-25
Q1 2017	$2.43M	-$8.11M	-76.9%	Apr 30, 2017	10-Q	2017-06-08
Q4 2016	$2.19M	-$16.3M	-88.1%	Jan 31, 2017	10-Q	2017-03-02
Q3 2016	$2.84M	-$4.74M	-62.5%	Oct 31, 2016	10-Q	2016-12-14
Q2 2016	$2.54M	+$1.67M	+192%	Jul 31, 2016	10-K	2017-10-26
Q1 2016	$10.5M	+$9.78M	+1282%	Apr 30, 2016	10-Q	2016-06-09
Q4 2015	$18.5M	+$17.6M	+2158%	Jan 31, 2016	10-Q	2016-03-09
Q3 2015	$7.58M	+$6.71M	+767%	Oct 31, 2015	10-Q	2015-12-10
Q2 2015	$869K	-$960K	-52.5%	Jul 31, 2015	10-K	2016-10-27
Q1 2015	$763K	-$393K	-34%	Apr 30, 2015	10-Q	2015-06-11
Q4 2014	$817K	-$696K	-46%	Jan 31, 2015	10-Q	2015-03-04
Q3 2014	$875K	-$1.46M	-62.5%	Oct 31, 2014	10-Q	2014-12-11
Q2 2014	$1.83M	-$324K	-15%	Jul 31, 2014	10-K	2015-10-28
Q1 2014	$1.16M	-$383K	-24.9%	Apr 30, 2014	10-Q	2014-06-10
Q4 2013	$1.51M	+$343K	+29.3%	Jan 31, 2014	10-Q	2014-03-13
Q3 2013	$2.33M	-$258K	-9.96%	Oct 31, 2013	10-Q	2013-12-12
Q2 2013	$2.15M	-$1.48M	-40.8%	Jul 31, 2013	10-K	2014-10-28
Q1 2013	$1.54M	-$745K	-32.6%	Apr 30, 2013	10-Q	2013-06-14
Q4 2012	$1.17M	-$700K	-37.4%	Jan 31, 2013	10-Q	2013-02-25

Previous1 2Next

Showing 1 to 50 of 56 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.